Syncope secondary to ventricular arrhythmia in a patient with amyloidosis: Is an ICD always the answer?
DOI:
https://doi.org/10.32818/reccmi.a3n2a14Keywords:
amyloidosis, syncope, arrhythmias, defibrillator.Abstract
A 76 year-old man was admitted to our hospital because of a first episode of heart failure, with severe left ventricular dysfunction and ventricular hypertrophy. We performed an angiography, which was normal, so he was discharged to be studied in an oupatient center. He is then readmitted because of syncope. In the electrocardiographic monitoring, non-sustained ventricular monomorfic tachyarrythmia was observed. Cardiac magnetic resonance and scintigraphy with Tc99 were compatible with cardiac amyloidosis. Confirmatory biopsy was not possible. We thought about implanting an automatic defibrillator, finally discarding it because of lack of evidence. Finally, the patient died from pulseless electrical activity.
Downloads
Metrics
References
García-Pavía P, Tomé-Esteban M, Rapezzi C. Amiloidosis. También una enfermedad de corazón. Rev Esp Cardiol. 2011; 64(9): 797-808.
Falk RH Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis. A review of diagnosis and therapy. J Am Coll Cardiol. 2016 Sep 20; 68(12): 1323-1341. Doi: https://doi.org/10.1016/j.jacc.2016.06.053.
Min-I S, Jui-Peng T, Sheng-Hsiung C, Cheng-Huang S. Cardiac amyloidosis presenting as recurrent syncope. Acta Cardiol Sin. 2014; 30(1): 86-89.
Goldsmith YB, Liu J, Chou J, et al. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring. Am J Cardiol. 2009; 104: 990-999.
Kojima T, Imai Y, Fujiu K, Suzuki T, Sugiyama H, Asada K, et al. Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis. J Arrhythm. 2012; 28: 242-246.
Hamon D, Algalarrondo V, Gandjbakhch E, Extramiana F, Marijon E, Elbaz N, Selhane D, et al. Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis. Int. J. Cardiol. 2016 Nov 1; 222: 562-568. Doi: https://doi.org/10.1016/j.ijcard.2016.07.254.
Kristen AV, Dengler TJ, Hegenbart U, Schonland SO, Goldschmidt H, Sack FU, et al. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm. 2008 Feb; 5(2): 235-240. Doi: https://doi.org/10.1016/j.hrthm.2007.10.016.
Lin G, Dispenzieri A, Kyle R, Grogan M, Brady PA. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. J Cardiovasc Electrophysiol. 2013 Jul; 24(7): 793-798. Doi: https://doi.org/10.1111/jce.12123.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Susana Patricia Cabrera-Huerta, Francisco José Romero-Santana , Natalia Marrero-Negrín, José María Medina-Gil
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
